Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

HLSQTessera Defense & Homeland Security Inc.

OTC · CIK 0001739174
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC7372 Services-Prepackaged Software
FY end1231
XBRL facts556

Identity from submissions API

NameTessera Defense & Homeland Security Inc.
CIK0001739174
TickersHLSQ
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC7372 Services-Prepackaged Software
EIN823364020
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone972 545610935
Website—
Investor website—
Owner org06 Technology
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • BiomX Inc. (2019-11-01T00:00:00.000Z → 2026-09-09T00:00:00.000Z)
  • Chardan Healthcare Acquisition Corp. (2018-05-04T00:00:00.000Z → 2019-10-23T00:00:00.000Z)
Business address
850 NEW BURTON ROAD
SUITE 201
DOVER
DE
19904
DE
Mailing address
850 NEW BURTON ROAD
SUITE 201
DOVER
DE
19904
DE

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

585 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 25-NSE xslF25X02/primary_doc.xml 0001143313-26-000061 001-38762 261577236 34 5070
2026-11-16 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-120779 001-38762 261562454 34 23803
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127210 005-90744 261553871 34 11611
2026-10-23 8-K CURRENT REPORT 3.02,5.02,5.07,9.01 0001213900-26-112192 001-38762 261483062 34 218297 1 1
2026-10-19 8-K CURRENT REPORT 3.02,9.01 0001213900-26-110754 001-38762 261469928 34 201315 1 1
2026-10-13 8-K CURRENT REPORT 3.02,8.01,9.01 0001213900-26-109087 001-38762 261457611 34 199447 1 1
2026-10-08 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-108045 001-38762 261450471 34 208593
2026-10-08 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-108041 001-38762 261450454 34 34812
2026-10-07 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-26-107541 001-38762 261446725 34 406946 1 1
2026-10-06 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-107281 001-38762 261445637 34 2401827 1 1
2026-10-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-106995 005-90744 261442400 34 11894
2026-10-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-106878 005-90744 261441307 34 19903
2026-10-05 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-26-106872 001-38762 261441233 34 273964 1 1
2026-09-29 8-K CURRENT REPORT 7.01,9.01 0001213900-26-104363 001-38762 261419539 34 260373 1 1
2026-09-25 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-103589 001-38762 261412250 34 297843
2026-09-25 8-K CURRENT REPORT 1.01,9.01 0001213900-26-103251 001-38762 261406353 34 237668 1 1
2026-09-22 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-102245 001-38762 261397536 34 347056 1 1
2026-09-17 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-100950 005-90744 261386783 34 17542
2026-09-15 8-K CURRENT REPORT 5.03,7.01,9.01 0001213900-26-100156 001-38762 261381238 34 37996715 1 1
2026-09-15 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-100121 005-90744 261380802 34 24908
2026-09-09 8-K CURRENT REPORT 5.03,9.01 0001213900-26-098212 001-38762 261366669 34 210109 1 1
2026-09-01 8-K CURRENT REPORT 8.01,9.01 0001213900-26-096273 001-38762 261351646 34 206240 1 1
2026-09-01 8-K/A AMENDMENT NO. 1 TO FORM 8-K 8.01,9.01 0001213900-26-096272 001-38762 261351645 34 201449 1 1
2026-08-28 8-K CURRENT REPORT 8.01,9.01 0001213900-26-095146 001-38762 261341238 34 202054 1 1
2026-08-25 8-K CURRENT REPORT 5.07,9.01 0001213900-26-093565 001-38762 261316671 34 196437 1 1
2026-08-20 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001957515-26-000004 005-90744 261301019 34 6727
2026-08-19 10-Q QUARTERLY REPORT 0001213900-26-091780 001-38762 261296395 34 6987959 1 1
2026-08-14 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-090211 001-38762 261283071 34 26259
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097274 005-90744 261282876 34 11120
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-089094 005-90744 261273230 34 18329
2026-08-11 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-087839 001-38762 261264102 34 258880 1 1
2026-08-11 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-087834 001-38762 261264092 34 1681181
2026-07-28 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-082025 001-38762 261207990 34 210295 1 1
2026-07-27 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-081859 333-275935 261206566 33 9304
2026-07-17 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-079234 001-38762 261184362 34 751491
2026-07-14 424B3 PROSPECTUS 0001213900-26-078003 333-297129 261174981 33 165863
2026-07-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002295 333-297129 261175762 33 1855
2026-07-10 8-K CURRENT REPORT 8.01,9.01 0001213900-26-077250 001-38762 261169396 34 192748 1 1
2026-07-02 8-K CURRENT REPORT 4.01,9.01 0001213900-26-075072 001-38762 261152697 34 200788 1 1
2026-06-30 S-8 REGISTRATION STATEMENT 0001213900-26-073802 333-297173 261141537 33 443165 1 1
2026-06-29 S-1 REGISTRATION STATEMENT 0001213900-26-073197 333-297129 261136866 33 602381 1 1
2026-06-26 8-K CURRENT REPORT 5.07,9.01 0001213900-26-072673 001-38762 261130087 34 208844 1 1
2026-06-22 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-070669 001-38762 261107904 34 19881
2026-06-18 8-K CURRENT REPORT 7.01,9.01 0001213900-26-069911 001-38762 261100617 34 27395044 1 1
2026-06-16 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193805-26-000833 005-90744 261096277 34 31819
2026-06-16 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-069312 333-275935 261095720 33 9114
2026-06-12 8-K CURRENT REPORT 3.01,7.01,9.01 0001213900-26-068026 001-38762 261085076 34 207617 1 1
2026-06-12 8-K/A AMENDMENT NO. 1 TO FORM 8-K 9.01 0001213900-26-068018 001-38762 261085032 34 1245703 1 1
2026-06-08 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-066341 001-38762 261073642 34 1917816
2026-06-05 8-K CURRENT REPORT 3.02,9.01 0001213900-26-065850 001-38762 261069609 34 412091 1 1
2026-05-28 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193805-26-000712 005-90744 261038263 34 28162
2026-05-28 8-K CURRENT REPORT 5.02,9.01 0001213900-26-061772 001-38762 261028622 34 277700 1 1
2026-05-20 10-Q QUARTERLY REPORT 0001213900-26-059587 001-38762 261004793 34 4874231 1 1
2026-05-15 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-057677 001-38762 26986589 34 35026
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-056951 005-90744 26981425 34 20090
2026-05-05 8-K CURRENT REPORT 8.01 0001213900-26-052213 001-38762 26943587 34 350336 1 1
2026-04-30 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-26-050373 001-38762 26927017 34 694848 1 1
2026-04-24 DRS filename1.htm 0001213900-26-047482 377-09292 26893247 33 211423
2026-04-16 8-K FORM 8-K 7.01,8.01,9.01 0001213900-26-044722 001-38762 26868475 34 212080 1 1
2026-04-15 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193805-26-000468 005-90744 26865063 34 23600
2026-04-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-043226 005-90744 26859189 34 14830
2026-04-13 8-K CURRENT REPORT 1.01,2.01,3.02,7.01,9.01 0001213900-26-042811 001-38762 26856622 34 593734 1 1
2026-04-10 S-8 REGISTRATION STATEMENT 0001213900-26-042598 333-295000 26855752 33 211786 1 1
2026-04-10 8-K CURRENT REPORT 5.07 0001213900-26-042595 001-38762 26855736 34 193479 1 1
2026-04-10 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-042437 005-90744 26854635 34 76930
2026-04-10 8-K CURRENT REPORT 1.01,2.01,3.02,7.01,9.01 0001213900-26-042200 001-38762 26853283 34 307748 1 1
2026-04-01 8-K CURRENT REPORT 1.01,9.01 0001213900-26-038095 001-38762 26825253 34 578368 1 1
2026-03-27 8-K CURRENT REPORT 3.01,8.01,9.01 0001213900-26-035605 001-38762 26808187 34 202985 1 1
2026-03-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-034099 001-38762 26793944 34 4209096
2026-03-19 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-26-031587 001-38762 26772639 34 221530 1 1
2026-03-18 4 xslF345X06/ownership.xml 0001213900-26-031016 23059
2026-03-13 4 xslF345X05/ownership.xml 0001213900-26-027698 15857
2026-03-11 8-K FORM 8-K 5.07 0001213900-26-026174 001-38762 26743730 34 190499 1 1
2026-03-06 8-K CURRENT REPORT 5.02 0001213900-26-024344 001-38762 26728622 34 197957 1 1
2026-03-03 3 xslF345X02/ownership.xml 0001213900-26-023338 3054
2026-03-02 8-K CURRENT REPORT 5.02,8.01 0001213900-26-022301 001-38762 26707534 34 193030 1 1
2026-02-25 8-K CURRENT REPORT 5.02 0001213900-26-020374 001-38762 26678486 34 193865 1 1
2026-02-19 10-K ANNUAL REPORT 0001213900-26-018231 001-38762 26652541 34 9219020 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001182 005-90744 26642873 34 10889
2026-02-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000585 333-293308 26635831 33 1854
2026-02-13 424B3 PROSPECTUS 0001213900-26-016579 333-293308 26634492 33 161673
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015328 005-90744 26634346 34 11415
2026-02-13 8-K CURRENT REPORT 5.02 0001213900-26-016402 001-38762 26632644 34 190925 1 1
2026-02-13 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-016404 001-38762 26632566 34 786401
2026-02-12 CORRESP filename1.htm 0001213900-26-015681 5568
2026-02-12 UPLOAD filename1.pdf 0000000000-26-001510 333-293308 40168
2026-02-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193805-26-000123 005-90744 26622680 34 23124
2026-02-10 8-K CURRENT REPORT 2.01,5.02,9.01 0001213900-26-014298 001-38762 26616451 34 276887 1 1
2026-02-09 S-3 REGISTRATION STATEMENT 0001213900-26-013693 333-293308 26611980 33 407242 1 1
2026-02-03 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-011597 001-38762 26594524 34 785660
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-004299 005-90744 26580092 34 9488
2026-01-26 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-26-007701 005-90744 26560529 34 33109
2026-01-20 D xslFormDX01/primary_doc.xml 06b 0001213900-26-005642 021-570448 26542765 33 13863
2026-01-16 3 xslF345X02/ownership.xml 0001213900-26-005298 6132
2026-01-14 8-K FORM 8-K 3.03,5.02,5.03 0001213900-26-004348 001-38762 26533351 34 200109 1 1
2026-01-07 8-K CURRENT REPORT 1.02,9.01 0001213900-26-002160 001-38762 26515749 34 253049 1 1
2025-12-29 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-126161 001-38762 251610451 34 1277061 1 1
2025-12-11 8-K CURRENT REPORT 8.01 0001213900-25-120668 001-38762 251564994 34 193471 1 1
2025-12-08 8-K CURRENT REPORT 8.01 0001213900-25-118969 001-38762 251554701 34 196299 1 1
2025-11-25 8-K CURRENT REPORT 8.01 0001213900-25-114833 001-38762 251522398 34 197988 1 1
2025-11-17 8-K CURRENT REPORT 3.03,5.03,9.01 0001213900-25-111265 001-38762 251489362 34 208849 1 1
2025-11-12 10-Q QUARTERLY REPORT 0001213900-25-109186 001-38762 251472565 34 5392835 1 1
2025-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-25-108722 001-38762 251468931 34 268552 1 1
2025-10-17 8-K CURRENT REPORT 5.07 0001213900-25-099755 001-38762 251399159 34 196625 1 1
2025-10-17 8-K CURRENT REPORT 8.01 0001213900-25-099752 001-38762 251399145 34 195039 1 1
2025-08-28 ARS FORM ARS 0001213900-25-081874 001-38762 251274691 34 1731817
2025-08-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-081843 001-38762 251274435 34 1779639
2025-08-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-081814 001-38762 251274265 34 2275855 1 1
2025-08-19 8-K CURRENT REPORT 8.01 0001213900-25-078196 001-38762 251229834 34 193002 1 1
2025-08-15 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-25-077437 001-38762 251224575 34 1242592
2025-08-13 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-075656 333-275935 251211474 33 16006
2025-08-13 10-Q QUARTERLY REPORT 0001213900-25-075328 001-38762 251209199 34 5204458 1 1
2025-08-13 8-K CURRENT REPORT 2.02,9.01 0001213900-25-075272 001-38762 251208985 34 277424 1 1
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000495 005-90744 251194245 34 12238
2025-08-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000454 005-90744 251184494 34 11872
2025-07-30 8-K CURRENT REPORT 5.08 0001213900-25-068990 001-38762 251164465 34 186945 1 1
2025-07-08 8-K CURRENT REPORT 7.01,9.01 0001213900-25-061939 001-38762 251109677 34 10584447 1 1
2025-06-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000626 005-90744 251065809 34 27096
2025-06-09 8-K CURRENT REPORT 7.01,9.01 0001213900-25-052377 001-38762 251032986 34 22273087 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049531 005-90744 25954456 34 11402
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002387 005-90744 25954000 34 9922
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-044185 005-90744 25952644 34 33681
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044157 001-38762 25952418 34 5021647 1 1
2025-05-15 8-K CURRENT REPORT 2.02,9.01 0001213900-25-043699 001-38762 25948815 34 278486 1 1
2025-05-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-009161 005-90744 25923930 34 9436
2025-04-24 424B3 PROSPECTUS 0001213900-25-034819 333-286496 25863812 33 215213
2025-04-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001211 333-286496 25863375 33 1825
2025-04-23 4 xslF345X05/e664432_4-biomx.xml 0001193805-25-000549 26126
2025-04-23 8-K CURRENT REPORT 5.07 0001213900-25-034623 001-38762 25861667 34 203877 1 1
2025-04-21 CORRESP filename1.htm 0001213900-25-033519 5559
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033490 5877
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033487 7708
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033485 7735
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033483 5909
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033480 5874
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033478 5880
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033476 6387
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033472 5914
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033468 5878
2025-04-21 4/A xslF345X05/ownership.xml 0001213900-25-033466 7712
2025-04-18 4 xslF345X05/e664417_4-biomx.xml 0001193805-25-000531 12791
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033360 7342
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033359 5509
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033358 5512
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033357 6018
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033356 5540
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033355 7338
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033354 5505
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033353 5511
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033352 7366
2025-04-18 4 xslF345X05/ownership.xml 0001213900-25-033351 5545
2025-04-17 DEFA14A AMENDMENT NO. 2 TO FORM DEFA14A 0001213900-25-033038 001-38762 25848476 34 52507
2025-04-17 UPLOAD filename1.pdf 0000000000-25-004075 333-286496 40106
2025-04-11 S-1 REGISTRATION STATEMENT 0001213900-25-031169 333-286496 25833641 33 417586
2025-04-01 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-027111 001-38762 25799573 34 15254
2025-03-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-025820 001-38762 25789192 34 31999152 1 1
2025-03-27 DEF 14A PROXY STATEMENT 0001013762-25-003352 001-38762 25779278 34 2969604
2025-03-25 10-K ANNUAL REPORT 0001013762-25-002283 001-38762 25769444 34 9872441 1 1
2025-03-25 8-K CURRENT REPORT 2.02,9.01 0001013762-25-001826 001-38762 25765737 34 274370 1 1
2025-03-17 PRE 14A PROXY STATEMENT 0001213900-25-024591 001-38762 25745459 34 2971750
2025-03-05 8-K CURRENT REPORT 8.01 0001213900-25-020788 001-38762 25712389 34 195157 1 1
2025-03-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-032501 005-90744 25706794 34 7422
2025-03-04 4 4 0000950170-25-032202 3465
2025-03-04 5 5 0000950170-25-032174 8124
2025-03-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193805-25-000259 005-90744 25700717 34 31052
2025-03-03 4 xslF345X05/e664242_4-biomx.xml 0001193805-25-000258 37393
2025-02-27 8-K CURRENT REPORT 1.01,3.02,7.01,8.01,9.01 0001213900-25-017728 001-38762 25674399 34 28994632 1 1
2025-02-27 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-017726 333-275935 25674353 33 444477
2025-02-27 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-017723 333-278986 25674319 33 22690
2025-02-24 424B5 424B5 0001213900-25-016658 333-275935 25658275 33 11838
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021160 005-90744 25628225 34 8005
2024-12-16 8-K CURRENT REPORT 8.01 0001213900-24-109057 001-38762 241550315 34 197897 1 1
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098523 001-38762 241463702 34 5953355 1 1
2024-11-14 8-K CURRENT REPORT 2.02,9.01 0001213900-24-097777 001-38762 241457006 34 285259 1 1
2024-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-117834 005-90744 241455843 34 12116
2024-11-13 SC 13G/A SC 13G/A 0001104659-24-117810 005-90744 241455642 34 101846
2024-11-04 SC 13G/A SC 13G/A 0001140361-24-045100 005-90744 241423466 34 90092
2024-10-31 15-12G FORM 15-2G 0001213900-24-092901 001-38762 241415567 34 10588
2024-10-28 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-091179 005-90744 241400836 34 131004
2024-10-25 25-NSE xslF25X02/primary_doc.xml 0000876661-24-001016 001-38762 241394832 34 4316
2024-10-15 8-K CURRENT REPORT 3.01 0001213900-24-087459 001-38762 241369227 34 243113 1 1
2024-09-26 8-K CURRENT REPORT 7.01,9.01 0001213900-24-081948 001-38762 241326148 34 18576175 1 1
2024-09-18 4 xslF345X05/ownership.xml 0001213900-24-079864 4919
2024-09-18 4 xslF345X05/ownership.xml 0001213900-24-079863 4941
2024-09-18 4 xslF345X05/ownership.xml 0001213900-24-079862 4910
2024-09-12 S-8 REGISTRATION STATEMENT 0001213900-24-078143 333-282059 241294923 33 96861
2024-08-16 8-K CURRENT REPORT 3.03,5.03,9.01 0001213900-24-070272 001-38762 241217088 34 266232 1 1
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068981 001-38762 241207394 34 5896002 1 1
2024-07-29 8-K CURRENT REPORT 3.01 0001013762-24-001812 001-38762 241149026 34 261848 1 1
2024-07-17 SC 13D/A AMENDMENT NO. 5 0000947871-24-000626 005-90744 241123518 34 119095
2024-07-17 4 xslF345X05/e663787_4-biomx.xml 0001193805-24-000938 29881
2024-07-16 424B3 PROSPECTUS 0001213900-24-061767 333-278986 241119605 33 412156
2024-07-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-15 17:00:00 9999999995-24-002160 333-278986 241118517 33 1848
2024-07-15 4 xslF345X05/e663780_4-biomx.xml 0001193805-24-000919 13006
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061463 5561
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061462 5525
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061461 5566
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061460 5570
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061458 5591
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061457 6034
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061456 5556
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061454 5527
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061452 5521
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061451 5557
2024-07-15 4 xslF345X05/ownership.xml 0001213900-24-061449 5527
2024-07-11 SC 13D/A e663774_sc13da-biomx.htm 0001193805-24-000910 005-90744 241112945 34 126296
2024-07-11 4 xslF345X05/e663773_4-biomx.xml 0001193805-24-000909 32978
2024-07-11 CORRESP filename1.htm 0001213900-24-060734 5794
2024-07-11 S-3/A AMENDMENT NO. 2 TO FORM S-3 0001213900-24-060731 333-278986 241111597 33 510065
2024-07-09 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-24-060155 333-278986 241108001 33 537778
2024-07-09 8-K CURRENT REPORT 5.02,5.03,5.07,9.01 0001213900-24-060128 001-38762 241107629 34 514950 1 1
2024-06-17 ARS ANNUAL REPORT 0001213900-24-053333 001-38762 241048368 34 696780
2024-06-17 UPLOAD filename1.pdf 0000000000-24-006923 001-38762 39899
2024-06-17 DEF 14A PROXY STATEMENT 0001213900-24-053210 001-38762 241047331 34 24966520
2024-06-13 PRER14A PRER14A 0001213900-24-052378 001-38762 241040786 34 10986479
2024-06-13 CORRESP filename1.htm 0001213900-24-052288 21535
2024-06-11 UPLOAD filename1.pdf 0000000000-24-006718 001-38762 47595
2024-05-30 SC 13D/A AMENDMENT NO. 1 TO SC 13D 0001193805-24-000728 005-90744 241007159 34 124401
2024-05-30 8-K/A AMENDMENT NO. 1 TO FORM 8-K 9.01 0001213900-24-048040 001-38762 241006400 34 793255 1 1
2024-05-30 8-K FORM 8-K 3.01,5.02 0001213900-24-048030 001-38762 241006260 34 256175 1 1
2024-05-28 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-24-047153 001-38762 24993101 34 7133592
2024-05-20 10-Q QUARTERLY REPORT 0001213900-24-045273 001-38762 24965943 34 4834144 1 1
2024-05-20 4 xslF345X05/ownership.xml 0000947871-24-000498 16023
2024-05-17 4 4 0000950170-24-061622 7114
2024-05-15 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-24-043596 001-38762 24950395 34 19211
2024-05-06 UPLOAD filename1.pdf 0000000000-24-005153 333-278986 40350
2024-04-29 S-3 REGISTRATION STATEMENT 0001213900-24-037203 333-278986 24891499 33 575112
2024-04-15 3 xslF345X02/ownership.xml 0001213900-24-033092 3057
2024-04-15 8-K CURRENT REPORT 5.02,5.03,9.01 0001213900-24-033032 001-38762 24845490 34 449553 1 1
2024-04-04 S-8 REGISTRATION STATEMENT 0001213900-24-030067 333-278500 24821625 33 115325
2024-04-04 10-K ANNUAL REPORT 0001213900-24-030053 001-38762 24821575 34 8967573 1 1
2024-04-03 8-K CURRENT REPORT 2.02,9.01 0001213900-24-029582 001-38762 24816866 34 335878 1 1
2024-04-01 NT 10-K NOTIFICATION OF LATE FILING 0001213900-24-028708 001-38762 24809029 34 29665
2024-04-01 D xslFormDX01/primary_doc.xml 06b 0001213900-24-028241 021-509186 24805706 33 15476
2024-03-26 SC 13G/A SC 13G/A 0001193125-24-077644 005-90744 24784063 34 48535
2024-03-26 3 3 0000950170-24-036452 9649
2024-03-25 SC 13G SC 13G 0001104659-24-038400 005-90744 24778934 34 108329
2024-03-22 SC 13D e619413_sc13d-biomx.htm 0001193805-24-000439 005-90744 24776423 34 183570
2024-03-21 3 xslF345X02/ownership.xml 0001213900-24-024777 3065
2024-03-21 3 xslF345X02/ownership.xml 0001213900-24-024775 3023
2024-03-21 3 xslF345X02/ownership.xml 0001213900-24-024773 3052
2024-03-21 8-K/A AMENDMENT NO. 1 TO FORM 8-K 5.02 0001213900-24-024771 001-38762 24771621 34 261115 1 1
2024-03-19 4 xslF345X05/e619387_4-biomx.xml 0001193805-24-000414 38616
2024-03-19 3 xslF345X02/e619384_3-biomx.xml 0001193805-24-000413 50534
2024-03-19 SC 13D/A AMENDMENT NO. 4 0000947871-24-000290 005-90744 24766065 34 121401
2024-03-19 4 xslF345X05/ownership.xml 0000947871-24-000289 16228
2024-03-18 8-K CURRENT REPORT 2.01,3.02,3.03,5.02,5.03,8.01,9.01 0001213900-24-023201 001-38762 24756920 34 399586 1 1
2024-03-08 SC 13D/A AMENDMENT NO. 3 0000947871-24-000273 005-90744 24734888 34 122704
2024-03-06 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001213900-24-020282 001-38762 24724389 34 8839562 1 1
2024-02-13 SC 13G/A FORM SC 13G/A 0001062993-24-002938 005-90744 24624192 34 58063
2024-02-02 SC 13G/A SCHEDULE 13G/A 0000904454-24-000096 005-90744 24592616 34 36538
2024-01-30 SC 13G/A SC 13G/A 0001193125-24-019410 005-90744 24578186 34 51866
2024-01-02 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-01-02 16:00:00 9999999995-24-000032 333-275935 24504282 33 1847
2023-12-29 CORRESP filename1.htm 0001213900-23-099517 7406
2023-12-28 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-23-099239 333-275935 231522787 33 422916
2023-12-13 4 xslF345X05/ownership.xml 0001213900-23-095420 18585
2023-12-13 4 xslF345X05/ownership.xml 0001213900-23-095419 13430
2023-12-13 4 xslF345X05/ownership.xml 0001213900-23-095417 18625
2023-12-13 4 xslF345X05/ownership.xml 0001213900-23-095415 13411
2023-12-12 SC TO-I/A AMENDMENT NO. 2 TO FORM SC TO-I 0001213900-23-095110 005-90744 231481493 34 20853
2023-12-11 3 xslF345X02/ownership.xml 0001213900-23-094761 2946
2023-12-07 8-K CURRENT REPORT 1.01,1.02,9.01 0001213900-23-094137 001-38762 231473428 34 264261 1 1
2023-12-07 S-3 REGISTRATION STATEMENT 0001213900-23-094106 333-275935 231473048 33 820543
2023-12-07 8-K CURRENT REPORT 8.01,9.01 0001213900-23-094060 001-38762 231472456 34 773890 1 1
2023-12-01 4 xslF345X05/ownership.xml 0001213900-23-092074 7493
2023-11-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-23-090704 001-38762 231448403 34 18394703 1 1
2023-11-28 CORRESP filename1.htm 0001213900-23-090550 24868
2023-11-28 SC TO-I/A AMENDMENT NO. 1 TO FORM SC TO-I 0001213900-23-090546 005-90744 231446303 34 376224
2023-11-21 UPLOAD filename1.pdf 0000000000-23-012759 50414
2023-11-14 10-Q QUARTERLY REPORT 0001213900-23-086662 001-38762 231403408 34 3912217 1 1
2023-11-14 8-K CURRENT REPORT 2.02,9.01 0001213900-23-086410 001-38762 231401555 34 352283 1 1
2023-11-09 SC TO-I TENDER OFFER STATEMENT 0001213900-23-085335 005-90744 231393870 34 7745479
2023-10-31 4 xslF345X05/ownership.xml 0001213900-23-081868 7984
2023-10-31 4 xslF345X05/ownership.xml 0001213900-23-081861 5484
2023-10-31 4 xslF345X05/ownership.xml 0001213900-23-081860 17770
2023-10-31 4 xslF345X05/ownership.xml 0001213900-23-081857 17728
2023-10-31 8-K CURRENT REPORT 5.02 0001213900-23-081855 001-38762 231365546 34 256327 1 1
2023-10-23 4 xslF345X05/ownership.xml 0001013762-23-005831 5432
2023-10-18 3 xslF345X02/ownership.xml 0001013762-23-004640 2912
2023-10-18 8-K CURRENT REPORT 5.02 0001013762-23-004638 001-38762 231330978 34 253336 1 1
2023-09-29 SC 13G SCHEDULE 13G 0001213900-23-080762 005-90744 231292353 34 158808
2023-08-29 8-K CURRENT REPORT 5.07 0001213900-23-071719 001-38762 231221898 34 254879 1 1
2023-08-23 4 xslF345X05/ownership.xml 0001213900-23-070256 5475
2023-08-23 4 xslF345X05/ownership.xml 0001213900-23-070255 5444
2023-08-09 10-Q QUARTERLY REPORT 0001213900-23-064926 001-38762 231154562 34 3644704 1 1
2023-08-09 8-K CURRENT REPORT 2.02,9.01 0001213900-23-064747 001-38762 231153289 34 356016 1 1
2023-07-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-060470 001-38762 231121216 34 934674
2023-07-14 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-23-056922 001-38762 231088025 34 412245
2023-06-23 SC 13G SC 13G 0001140361-23-031215 005-90744 231038433 34 94185
2023-06-20 8-K CURRENT REPORT 5.07 0001213900-23-050060 001-38762 231025301 34 253741 1 1
2023-06-12 25-NSE xslF25X02/primary_doc.xml 0001143313-23-000040 001-38762 231007345 34 4994
2023-06-09 424B3 PROSPECTUS 0001213900-23-047815 333-272371 231005137 33 127450
2023-06-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-08 16:30:00 9999999995-23-001694 333-272371 231003757 33 1799
2023-06-08 8-K CURRENT REPORT 3.01 0001213900-23-047490 001-38762 231002307 34 261333 1 1
2023-06-06 CORRESP filename1.htm 0001213900-23-046799 7048
2023-06-06 UPLOAD filename1.pdf 0000000000-23-005994 40278
2023-06-02 S-3 REGISTRATION STATEMENT 0001213900-23-045732 333-272371 23988552 33 240795
2023-05-24 4 xslF345X04/ownership.xml 0001213900-23-042514 5080
2023-05-22 4 xslF345X04/ownership.xml 0001213900-23-041960 7069
2023-05-19 3 xslF345X02/ownership.xml 0001213900-23-041510 2961
2023-05-19 3 xslF345X02/ownership.xml 0001213900-23-041509 2947
2023-05-15 10-Q QUARTERLY REPORT 0001213900-23-039734 001-38762 23921800 34 3529832 1 1
2023-05-15 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-039674 001-38762 23921451 34 21769
2023-05-15 8-K CURRENT REPORT 2.02,5.02,9.01 0001213900-23-039291 001-38762 23918454 34 357223 1 1
2023-05-08 SC 13D/A AMENDMENT NO. 2 0000947871-23-000538 005-90744 23898407 34 127514
2023-05-05 8-K CURRENT REPORT 3.02 0001213900-23-036661 001-38762 23891491 34 261663 1 1
2023-05-01 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-034600 001-38762 23874420 34 656219
2023-05-01 ARS FORM ARS 0001213900-23-034629 001-38762 23873710 34 1486731
2023-05-01 DEFA14A DEFA14A 0001213900-23-034618 001-38762 23873576 34 147065
2023-04-25 8-K CURRENT REPORT 5.07 0001213900-23-032477 001-38762 23844775 34 260390 1 1
2023-03-29 S-8 REGISTRATION STATEMENT 0001213900-23-024137 333-270947 23776002 33 75204
2023-03-29 10-K ANNUAL REPORT 0001213900-23-024122 001-38762 23775721 34 6986703 1 1
2023-03-29 8-K CURRENT REPORT 2.02,5.08,9.01 0001213900-23-023846 001-38762 23771782 34 340692 1 1
2023-03-22 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-022102 001-38762 23753343 34 832648
2023-03-17 4 xslF345X03/ownership.xml 0000947871-23-000336 14218
2023-03-17 SC 13D/A AMENDMENT NO. 1 0000947871-23-000335 005-90744 23742862 34 121102
2023-03-09 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-23-018923 001-38762 23720719 34 102607
2023-03-08 SC 13G SC 13G 0001193125-23-064693 005-90744 23717202 34 52970
2023-03-03 D xslFormDX01/primary_doc.xml 06b 0001213900-23-017225 021-474875 23703962 33 11080
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017221 5405
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017218 5415
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017217 5447
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017216 5453
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017212 5453
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017209 5471
2023-03-03 4 xslF345X03/ownership.xml 0001213900-23-017206 5437
2023-02-27 8-K CURRENT REPORT 1.01,9.01 0001213900-23-014891 001-38762 23676501 34 365974 1 1
2023-02-22 8-K CURRENT REPORT 1.01,3.02,7.01,8.01,9.01 0001213900-23-013615 001-38762 23652735 34 5882139 1 1
2023-02-14 SC 13G/A FORM SC 13G/A 0001062993-23-003289 005-90744 23625963 34 63766
2023-02-13 SC 13G/A SCHEDULE 13G/A (AMENDMENT NO. 2) 0001014108-23-000034 005-90744 23618083 34 58344
2023-01-26 8-K CURRENT REPORT 7.01,9.01 0001213900-23-005234 001-38762 23554223 34 8604632 1 1
2023-01-06 8-K CURRENT REPORT 5.02 0001213900-23-001398 001-38762 23515441 34 258303 1 1
2022-11-14 4 PRIMARY DOCUMENT 0001014108-22-000163 27676
2022-11-14 4 PRIMARY DOCUMENT 0001014108-22-000162 37513
2022-11-14 4 PRIMARY DOCUMENT 0001014108-22-000161 45659
2022-11-14 SC 13G/A SCHEDULE 13 G/A (AMENDMENT NO. 1) 0001014108-22-000160 005-90744 221387515 34 58933
2022-11-09 10-Q QUARTERLY REPORT 0001213900-22-070435 001-38762 221371200 34 3517012 1 1
2022-11-09 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-22-070348 001-38762 221370653 34 3659566 1 1
2022-08-29 8-K CURRENT REPORT 5.07 0001213900-22-051792 001-38762 221211248 34 292487 1 1
2022-08-24 4 xslF345X03/ownership.xml 0001213900-22-050774 5453
2022-08-24 4 xslF345X03/ownership.xml 0001213900-22-050773 5475
2022-08-24 4 xslF345X03/ownership.xml 0001213900-22-050772 5450
2022-08-10 10-Q QUARTERLY REPORT 0001213900-22-046257 001-38762 221151386 34 3284310 1 1
2022-08-10 8-K CURRENT REPORT 2.02,9.01 0001213900-22-046071 001-38762 221150361 34 365517 1 1
2022-08-05 SC 13G/A SC 13G/A 0001395064-22-000132 005-90744 221138266 34 69350
2022-07-07 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-037937 001-38762 221071686 34 489383
2022-07-07 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-037933 001-38762 221071671 34 799547
2022-07-06 8-K CURRENT REPORT 8.01 0001213900-22-037424 001-38762 221067336 34 259608 1 1
2022-06-27 8-K CURRENT REPORT 8.01 0001213900-22-035187 001-38762 221044545 34 272857 1 1
2022-06-21 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-22-033989 001-38762 221028498 34 802471
2022-06-14 8-K CURRENT REPORT 5.08,7.01,9.01 0001213900-22-032824 001-38762 221015343 34 5190612 1 1
2022-05-24 8-K CURRENT REPORT 8.01 0001213900-22-029276 001-38762 22956642 34 261516 1 1
2022-05-11 10-Q QUARTERLY REPORT 0001213900-22-025542 001-38762 22913339 34 2796006 1 1
2022-05-11 8-K CURRENT REPORT 2.02,9.01 0001213900-22-025390 001-38762 22912106 34 340198 1 1
2022-05-02 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-22-023189 001-38762 22882146 34 841781 1 1
2022-04-08 424B5 PROSPECTUS SUPPLEMENT 0001213900-22-018939 333-251151 22816994 33 17418
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016995 5407
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016991 5416
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016988 5451
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016986 5459
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016980 5454
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016969 5473
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016958 5402
2022-03-31 4 xslF345X03/ownership.xml 0001213900-22-016950 5391
2022-03-30 S-8 REGISTRATION STATEMENT 0001213900-22-016245 333-263995 22787682 33 86658
2022-03-30 10-K ANNUAL REPORT 0001213900-22-016136 001-38762 22786364 34 6696091 1 1
2022-03-30 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-22-015956 001-38762 22783166 34 5569531 1 1
2022-02-14 4 PRIMARY DOCUMENT 0001014108-22-000058 7394
2022-02-14 SC 13G SCHEDULE 13G, AMENDMENT 1 0001014108-22-000055 005-90744 22631757 34 60026
2022-02-14 SC 13G SCHEDULE 13G 0001014108-22-000048 005-90744 22630867 34 60555
2022-02-14 3 PRIMARY DOCUMENT 0001014108-22-000043 6137
2022-02-04 SC 13G/A FORM SC 13G/A 0001062993-22-002558 005-90744 22590522 34 57850
2022-01-04 D xslFormDX01/primary_doc.xml 06b 0001213900-22-000469 021-427825 22505704 33 12430
2021-12-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-12-13 16:00:00 9999999995-21-004669 333-261419 211489582 33 1799
2021-12-09 CORRESP filename1.htm 0001213900-21-064389 13052
2021-12-08 UPLOAD filename1.pdf 0000000000-21-014741 40228
2021-11-30 S-3 REGISTRATION STATEMENT 0001213900-21-062598 333-261419 211460161 33 273366
2021-11-15 10-Q QUARTERLY REPORT 0001213900-21-059179 001-38762 211408887 34 3243376 1 1
2021-11-15 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-21-058956 001-38762 211406343 34 5571864 1 1
2021-10-25 D xslFormDX01/primary_doc.xml 06b 0001213900-21-054333 021-418311 211342221 33 12217
2021-10-18 8-K CURRENT REPORT 8.01 0001213900-21-053135 001-38762 211327331 34 271150 1 1
2021-10-18 SC 13G/A SC 13G/A 0001395064-21-000206 005-90744 211327238 34 68418
2021-08-17 4/A xslF345X03/ownership.xml 0001213900-21-043458 7211
2021-08-16 10-Q QUARTERLY REPORT 0001213900-21-043096 001-38762 211179422 34 3459289 1 1
2021-08-16 8-K CURRENT REPORT 2.02,9.01 0001213900-21-042697 001-38762 211175106 34 94817
2021-08-09 SC 13G SCHEDULE 13G 0001014108-21-000155 005-90744 211156875 34 54575
2021-08-09 3 PRIMARY DOCUMENT 0001014108-21-000152 5606
2021-07-30 4 xslF345X03/ownership.xml 0000947871-21-000844 11118
2021-07-30 4 OWNERSHIP DOCUMENT 0001213900-21-039441 7448
2021-07-30 4 OWNERSHIP DOCUMENT 0001213900-21-039439 7445
2021-07-30 4 OWNERSHIP DOCUMENT 0001213900-21-039437 7463
2021-07-30 4 xslF345X03/ownership.xml 0001213900-21-039435 8109
2021-07-30 4 OWNERSHIP DOCUMENT 0001213900-21-039433 7425
2021-07-30 4 OWNERSHIP DOCUMENT 0001213900-21-039431 7405
2021-07-28 4 xslF345X03/ownership.xml 0001213900-21-039171 6917
2021-07-28 4 xslF345X03/ownership.xml 0001213900-21-039168 6908
2021-07-26 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-038619 333-251151 211114083 33 685886
2021-07-26 8-K CURRENT REPORT 1.01,2.02,7.01,9.01 0001213900-21-038525 001-38762 211112620 34 555422
2021-06-21 8-K CURRENT REPORT 5.07 0001213900-21-033065 001-38762 211027023 34 25401
2021-05-24 10-Q QUARTERLY REPORT 0001213900-21-028654 001-38762 21952082 34 2682937 1

Latest XBRL company facts

One latest value per concept from companyfacts (556 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 26.72M 2026-08-18 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
dei EntityPublicFloat Entity Public Float USD 11.90M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001213900-26-050373
ffd NetFeeAmt NetFeeAmt USD 258.63 2026-06-30 S-8 2026-06-30 0001213900-26-073802
ffd TtlFeeAmt TtlFeeAmt USD 258.63 2026-06-30 S-8 2026-06-30 0001213900-26-073802
ffd TtlOfferingAmt TtlOfferingAmt USD 1.87M 2026-06-30 S-8 2026-06-30 0001213900-26-073802
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-06-30 S-8 2026-06-30 0001213900-26-073802
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 50,000 2020-09-01 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 738,409 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 5.45M 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 2.96M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.36M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap AccountsPayableInterestBearingInterestRate Accounts Payable, Interest-bearing, Interest Rate pure 0.5 2020-09-01 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 1.13M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 1.13M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 908,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 327,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 100,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 1.06M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 5.43M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Reclassifications from Property, Plant and Equipment USD 1.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD -21,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -143.16M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap AdditionalCollateralAggregateFairValue Additional Collateral, Aggregate Fair Value USD 148,000 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 244.47M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD -19,000 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD -1.74M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 2.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 54,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 2.89M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.16M 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.06M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 567,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1.52M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap AmortizationOfRegulatoryAsset Amortization of Regulatory Asset USD 1.52M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap AmountOfRegulatoryAssistanceReceived1 Amount of Regulatory Assistance Received ILS 2.04M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043096
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 58,879 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap AreaOfLand Area of Land sqm 49,625 2019-08-09 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred USD 15.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 11.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap Assets Assets USD 28.19M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AssetsCurrent Assets, Current USD 2.42M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 13,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AssetsNoncurrent Assets, Noncurrent USD 25.77M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 2.40M 2026-02-04 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 120,000 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap BankruptcyClaimsNumberOfClaimsSettled Bankruptcy Claims, Number of Claims Settled pure 2,118 2021-03-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap BasicEarningsPerShareProForma Basic Earnings Per Share, Pro Forma USD/shares 1.95 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 741,000 2024-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044157
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.5 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 21.37M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 60.10M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0001213900-22-025542
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset USD 116,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 3,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap BusinessCombinationContingentConsiderationAsset Business Combination, Contingent Consideration, Asset USD 8.25M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 2.30M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 419,000 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043096
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 30.23M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 509,000 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 1.78M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 3.67M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other USD 2.90M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 16.09M 2024-03-15 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 14.38M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 15.85M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 3.75M 2024-03-15 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 15.85M 2024-03-15 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed USD 874,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap BusinessDevelopment Business Development USD 4.70M 2020-10-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap Capital Banking Regulation, Total Capital, Actual ILS 10,036 2024-03-21 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 5,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 304,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap Cash Cash USD 5.00M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 347,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 11.38M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -599,592 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 38.71M 2022-06-30 2022 Q2 10-Q 2022-08-10 0001213900-22-046257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 347,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -4.61M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.00M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 12.27M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 533,360 2025-05-11 2025 Q1 10-Q 2025-05-15 0001213900-25-044157
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 21.93M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.01M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap CommonStockConvertibleConversionPriceIncrease Common Stock, Convertible, Conversion Price, Increase USD/shares 2 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 750.00M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 12.59M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 12.59M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 32.00M 2017-11-30 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -23.05M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 74,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -22.99M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 2.43M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 1.98M 2021-10-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.98M 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 1.98M 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 1.98M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 12.61M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 3,300 2026-03-17 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CostOfRevenue Cost of Revenue USD 235,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 136,419 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 5.58M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 25,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 15,000 2021-08-16 2021 Q3 10-Q 2021-11-15 0001213900-21-059179
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 10.75M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.191 2023-06-30 2023 Q2 10-Q 2023-08-09 0001213900-23-064926
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 94,000 2024-03-19 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD -440,000 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 1.86M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -1,222 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 440,000 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap DeferredIncome Deferred Income USD 28,000 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 1,222 2019-06-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 1,222 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 6.84M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 627 2019-03-31 2019 Q3 10-Q 2019-05-10 0001615774-19-007490
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 64,545 2018-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.19M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 64.46M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 601,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 1,222 2019-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 51.58M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 13.58M 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.04M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 310,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 14.47M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 8.74M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.03M 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 57.62M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.08M 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 127,000 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DeferredTaxLiabilitiesOtherFiniteLivedAssets Deferred Tax Liabilities, Other Finite-Lived Assets USD 16,000 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 190,000 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) USD 3.79M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap DefinedContributionPlanAdministrativeExpenses Defined Contribution Plan, Administrative Expense USD 354,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 5,000 2019-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap Depreciation Depreciation USD 5,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD -1.77M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 882,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 19,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap DerivativeUnderlyingInvestmentShares DerivativeUnderlyingInvestmentShares shares 9.21M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap DevelopmentInProcess Development in Process USD 15.29M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap DilutedEarningsPerShareProForma Diluted Earnings Per Share Pro Forma USD/shares 1.95 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap DirectTaxesAndLicensesCosts Cost, Direct Tax and License USD 10,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents USD 996,000 2026-02-04 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Current USD 1.25M 2026-02-04 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current USD 157,000 2026-02-04 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 50,000 2019-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 50,000 2018-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007405
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 500,000 2019-06-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 3.56 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 1.39 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 3.56 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.095 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.009 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD 237,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 39,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 923 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 556,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.58M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap EquityFairValueAdjustment Equity, Fair Value Adjustment USD 7,818 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap EquityFairValueDisclosure Equity, Fair Value Disclosure USD 1.02M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap EquityMethodInvestmentAggregateCost Equity Method Investment, Aggregate Cost USD 3.00M 2021-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap EscrowDeposit Escrow Deposit USD 300,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 567,729 2017-11-30 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 216,417 2024-03-15 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap ExchangeFees Exchange Fees USD 439,000 2020-09-01 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 1,219 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap FairValueConcentrationOfRiskForeignCurrencyContractAsset Fair Value, Concentration of Risk, Foreign Currency Contract, Asset USD 544,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap FairValueConcentrationOfRiskLiabilitiesRelatedToInvestmentContracts FairValueConcentrationOfRiskLiabilitiesRelatedToInvestmentContracts USD 33,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 10.23M 2026-04-13 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 36.76M 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap ForeignCurrencyContractAssetFairValueDisclosure Foreign Currency Contract, Asset, Fair Value Disclosure USD 19,000 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ForeignCurrencyContractsLiabilityFairValueDisclosure Foreign Currency Contracts, Liability, Fair Value Disclosure USD 55,000 2022-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap ForeignCurrencyFairValueHedgeAssetAtFairValue Foreign Currency Fair Value Hedge Asset at Fair Value USD 62,000 2021-12-31 2022 Q3 10-Q 2022-11-09 0001213900-22-070435
us-gaap ForeignCurrencyFairValueHedgeLiabilityAtFairValue Foreign Currency Fair Value Hedge Liability at Fair Value USD 67,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001213900-22-070435
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD -364,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD -77,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 257,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 2.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -14.06M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -165,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -24,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 2.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 1.86M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.99M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap Goodwill Goodwill USD 801,000 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GoodwillFairValueDisclosure Goodwill, Fair Value Disclosure USD 18.00M 2026-04-13 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 801,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GoodwillOtherIncreaseDecrease Goodwill, Other Increase (Decrease) USD 300,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GovernmentAssistanceAmountCumulativeCurrent GovernmentAssistanceAmountCumulativeCurrent USD 116,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap GovernmentAssistanceAwardAmount GovernmentAssistanceAwardAmount ILS 32.07M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap GovernmentAssistanceLiabilityCurrent GovernmentAssistanceLiabilityCurrent USD 471,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap GovernmentContractReceivable Government Contract Receivable USD 90,000 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap GrantsReceivable Grants Receivable USD 8.93M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 1.17M 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap GrossProfit Gross Profit USD 97,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 4.05M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 496,000 2025-07-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -12.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -22.99M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -24.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -8.40M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028654
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 1.86M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest USD -1.86M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 3,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 3.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -481,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -7.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -18,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 3.74M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 154,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -279,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncreaseDecreaseDueFromOtherRelatedParties Increase (Decrease) Due from Other Related Parties USD -19,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 365,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028654
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 422,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -123,710 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 1.98M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 50,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 3,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD -1.57M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 1.42M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -2.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -40,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -633,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028654
us-gaap IncreaseDecreaseInPayablesToCustomers Increase (Decrease) in Payables to Customers USD -216,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012296
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -13,374 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -511,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 13.14M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 15,000 2017-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.52M 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap InterestAndOtherIncome Interest and Other Income USD 2,153 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap InterestExpense Interest Expense USD 850,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap InterestExpenseDebt Interest Expense, Debt USD 850,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 10.43M 2024-03-19 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 211,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap InterestExpenseOther Interest Expense, Other USD 983,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper Interest Income and Fees, Bankers Acceptances, Certificates of Deposit and Commercial Paper USD 1.12M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap InterestIncomeDepositsWithFinancialInstitutions Interest Income, Deposits with Financial Institutions USD 460,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -1.05M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap InterestIncomeOther Interest Income, Other USD 374,533 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 5,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 850,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 186,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LandAvailableForSale Land Available-for-sale USD 157,000 2025-12-31 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.10M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap LeaseCost Lease, Cost USD 1.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 4.45M 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap LeaseIncentivePayableCurrent Lease Incentive, Payable, Current USD 1.07M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap LeaseIncome Lease Income USD 1.03M 2020-09-30 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap LegalFees Legal Fees USD 1.41M 2022-06-23 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 12.54M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 627,000 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.95M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 914,000 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 5.05M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.02M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.98M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.95M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap Liabilities Liabilities USD 10.56M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 28.19M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LiabilitiesCurrent Liabilities, Current USD 10.18M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 2.17M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 383,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 4.26M 2026-02-04 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 3.00M 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap LineOfCreditFacilityCommitmentFeeAmount Line of Credit Facility, Commitment Fee Amount USD 89,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.12 2026-05-13 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure 0.01 2015-06-30 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap LinesOfCreditFairValueDisclosure Lines of Credit, Fair Value Disclosure USD 10.23M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LongTermDebt Long-term Debt USD 11.19M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 4.88M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043096
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 632,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 5.79M 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 5.79M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 4.74M 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 4.96M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 5.79M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 4.96M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 247,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.15 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 5.03M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ManufacturingCosts Manufacturing Costs ILS 5.74M 2021-08-31 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap MarketableSecurities Marketable Securities USD 71.08M 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 71.08M 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 372,380 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -5,821 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 6.76M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 13,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.53M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.55M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -6.58M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -22.99M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetIncomeLossAllocatedToLimitedPartners Net Income (Loss) Allocated to Limited Partners USD 28.32M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 74,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 36.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 23.07M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 22.86M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap NoncontrollingInterestInNetIncomeLossPreferredUnitHoldersNonredeemable Noncontrolling Interest in Net Income (Loss) Preferred Unit Holders, Nonredeemable USD 2.53M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007405
us-gaap NonoperatingGainsLosses Nonoperating Gains (Losses) USD -902,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -724,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 3.27M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 40,000 2018-06-30 2019 FY 10-K 2019-08-21 0001213900-19-016461
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 28,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007405
us-gaap OperatingExpenses Operating Expenses USD 376,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.71M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 96,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-13 0001213900-20-021892
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.58M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 8,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 13,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 155,000 2024-03-05 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 21,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 15.00M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001213900-21-059179
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 789,000 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 5.80M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001213900-21-059179
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.46M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001213900-21-059179
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 7.08M 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 95,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 763,000 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 789,000 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 789,000 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 832,000 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 722,000 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.06 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 108.36M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 2.96M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.42M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 2.59M 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 1.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap OtherAssets Other Assets USD 2.63M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.52M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherAssetsMiscellaneous Other Assets, Miscellaneous USD 16,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 172,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 96,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap OtherCommitment Other Commitment USD 32,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest USD -14,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent USD -7,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 7,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 892,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap OtherExpenses Other Expenses USD 657,000 2025-02-01 2025-02-28 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 199,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028654
us-gaap OtherIncome Other Income USD 141,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherLiabilities Other Liabilities USD 40,000 2022-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 5.45M 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap OtherLiabilitiesFairValueDisclosure Other Liabilities, Fair Value Disclosure USD 2.36M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 77,000 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 5.79M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap OtherNoncashIncome Other Noncash Income USD 53,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044157
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -382,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -377,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 1.25M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherOperatingIncome Other Operating Income USD 312,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.24M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 1.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 974,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 500,000 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap PaymentForContingentConsiderationLiabilityInvestingActivities Payment for Contingent Consideration Liability, Investing Activities USD 9.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 333,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 450,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap PaymentsForFees Payments for Other Fees USD 29,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 32.00M 2017-11-01 2017-11-30 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 11.50M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -2.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD 257,000 2020-09-01 2020-09-30 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap PaymentsForRent Payments for Rent USD 255,000 2019-08-09 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap PaymentsForRoyalties Payments for Royalties USD 8.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 118,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsOfDerivativeIssuanceCosts Payments of Derivative Issuance Costs USD 1.89M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 39,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 750,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 176,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 500,000 2022-06-23 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap PaymentsToAcquireInterestInSubsidiariesAndAffiliates Payments to Acquire Interest in Subsidiaries and Affiliates USD 378,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 29,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001213900-22-070435
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 2,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 13.50M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap PaymentsToInvestInDecommissioningFund Payments to Acquire Investments to be Held in Decommissioning Trust Fund USD -170,264 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap PercentageOfWeightedAverageCostInventory Percentage of Weighted Average Cost Inventory pure 0.19 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 2.17M 2024-03-15 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.24 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 3.59M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 51,598 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 51,598 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 6.51M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 129,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap PrepaidInsurance Prepaid Insurance USD 248,000 2025-12-31 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PrepaymentFeesOnAdvancesNet Prepayment Fees on Advances, Net USD 983,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044157
us-gaap PrincipalAmountOutstandingOfLoansHeldInPortfolio Principal Amount Outstanding of Loans Held-in-portfolio USD 983,000 2024-03-19 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 2.62M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 1.41M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 3.00M 2025-12-26 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 996,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 21.27M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 14.22M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 14.22M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 1.80M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.62M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 4.53M 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 10,000 2015-06-01 2015-06-30 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 7.49M 2023-02-22 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 656,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 7,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD -49,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012296
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 51,000 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 2.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 8.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001213900-22-070435
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 17.74M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 7.49M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 5.22M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ProfessionalFees Professional Fees USD 2.07M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -22.99M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ProFormaWeightedAverageSharesOutstandingDiluted Pro Forma Weighted Average Shares Outstanding, Diluted shares 6.61M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap PropertyPlantAndEquipmentFairValueDisclosure Property, Plant, and Equipment, Fair Value Disclosure USD 75,000 2026-04-13 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.59M 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 101,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 3.55M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD -6,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 300,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ReceivablesLongTermContractsOrPrograms Receivables, Long-term Contracts or Programs ILS 1.36M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap RedeemableNoncontrollingInterestEquityCommonCarryingAmount Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount USD 65.46M 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap ReductionsInOtherAssetsAmount Reductions in Other Assets, Amount USD 2,614 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 19,000 2019-10-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap RepaymentsOfDebt Repayments of Debt USD 4.25M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 48,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 500,000 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 21.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 16.24M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap RestrictedCash Restricted Cash USD 1.14M 2025-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 15.86M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 14.91M 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 595,000 2025-12-31 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 161,000 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap RestrictedInvestmentsAtFairValue Restricted Investments, at Fair Value USD 3.29M 2021-03-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -239.81M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 32.10M 2019-04-30 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap Revenues Revenues USD 332,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap RoyaltyExpense Royalty Expense USD 7.41M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap RoyaltyGuaranteesCommitmentsAmount Royalty Guarantees, Commitments, Amount USD 3.20M 2017-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007405
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 2.42M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 6,000 2024-01-01 2024-12-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044157
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 7,518 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap SaleOfStockPercentageOfOwnershipBeforeTransaction Sale of Stock, Percentage of Ownership before Transaction pure 1 2017-11-01 2017-11-30 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 2.71 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap SecurityDeposit Security Deposit USD 154,000 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap SeveranceCosts1 Severance Costs USD 348,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.06M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 530,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028654
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 1,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.99 2024-09-16 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 10.22 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.105 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.66 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.13 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.04 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 5,700 2019-10-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 9.52M 2024-03-15 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 363,382 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.08 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 38,662 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 3.63 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 170,460 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 151,100 2023-10-29 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.21M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 914,741 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 9,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.00M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.7 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.33M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1,311 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.55 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 2.83 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075328
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.5 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 0.01 2019-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007405
us-gaap SharePrice Share Price USD/shares 10.22 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap SharesIssued Shares, Issued shares 24.63M 2023-04-24 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 2.57 2021-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares shares 6.45M 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap ShortTermBorrowings Short-term Debt USD 210,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap ShortTermDebtInterestRateIncrease Short-term Debt, Interest Rate Increase pure 0.043 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.043 2022-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap ShortTermInvestments Short-term Investments USD 225,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 3.99M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationForfeited Shares Granted, Value, Share-based Payment Arrangement, Forfeited USD 3.60M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012296
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 510,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 10.87M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 17.62M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap StockIssued1 Stock Issued USD 3.04M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 3,300 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 3,300 2026-03-10 2026-03-17 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 250,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 923,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001213900-26-059587
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 155,429 2024-09-16 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 6.98M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 21,511 2024-07-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 2.01M 2018-09-13 2018-09-14 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 15.79M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 20.40M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 541,000 2024-01-01 2024-03-31 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 7.15M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-04 0001213900-24-030053
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 878,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 6.47M 2025-01-01 2025-03-31 2025 Q3 10-Q 2025-11-12 0001213900-25-109186
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 52,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 3.24M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 195,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044157
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD -19,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 5 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 2.75 2023-12-11 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 292,177 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 70,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 3.52M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001213900-26-018231
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 12,709 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap TaxesPayableCurrentAndNoncurrent Taxes Payable USD 87,713 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 4.58M 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 32.42M 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10 2019-09-30 2020 Q1 10-Q 2019-10-16 0001213900-19-020447
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 1.00M 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 256,887 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 256,887 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045273
us-gaap TravelAndEntertainmentExpense Travel and Entertainment Expense USD 160,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001213900-23-024122
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 570 2019-10-31 2024 FY 10-K 2025-03-25 0001013762-25-002283
us-gaap TreasuryStockShares Treasury Stock, Shares shares 5,700 2019-10-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 2.66M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019233
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 2.31 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 0.001 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098523
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 87,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap WeightedAverageBasicSharesOutstandingProForma Weighted Average Basic Shares Outstanding, Pro Forma shares 6.61M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068981
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 6.23M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 6.48M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 26.01M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016136
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 4.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086662
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 32.13M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039734
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 6.48M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001213900-26-091780

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →